THE HOBBS GROUP, LLC for JOHNSON & JOHNSON
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Proposed CMS national coverage decisions for the use of erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HOBBS | ASSISTANT TO THE PRESIDENT FOR LEGISLATIVE AFFAIR |
Taxation/Internal Revenue Code TAX
H.R.2138 - The Investment in America Act of 2007 S.41 - The Research Competitiveness Act of 2007
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HOBBS | ASSISTANT TO THE PRESIDENT FOR LEGISLATIVE AFFAIR |
Health Issues HCR
Proposed CMS national coverage decisions for the use of erythropoiesis stimulating agents (ESAs) in cancer and related neoplastic conditions, on privately-sponsored post-approval clinical trials, and the Inpatient Prospective Payment System.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID HOBBS | ASSISTANT TO THE PRESIDENT FOR LEGISLATIVE AFFAIR |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.